State of the Art Diagnostics Important to Detect, Diagnose and Personalize Treatment
WHAT: AdvaMed is holding a briefing for Congressional staff and the
media on the importance of molecular diagnostics in addressing
diseases that disproportionately impact the African-American
There are many chronic diseases that disproportionately impact
African-Americans that, if caught earlier and managed more
effectively, would save lives and reduce costs to the health care
A leading panel of experts will address the issue of health
disparities and ways to reduce them by improving access to
state of the art diagnostic laboratory tests.
-- Rep. Bobby L. Rush, D-Illinois
-- Del. Donna Christensen, D-Virgin Islands
-- Dr. Albert W. Morris, Immediate Past President, National Medical
Association and Diagnostic Radiologist
-- Millicent Gorham, Executive Director, National Black Nurses
-- Stephen J. Ubl, President and CEO, Advanced Medical Technology
WHEN: Tuesday, Oct. 30 at 12.30 pm to 1.30 p.m.
WHERE: 2218 Rayburn House Office Building
RSVP: Please email Mark Brager at firstname.lastname@example.org or call
202-434-7244 to cover the event.
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our members produce nearly 90 percent of the health care technology purchased annually in the United States and more than 50 percent purchased annually around the world. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit http://www.advamed.org.
/PRNewswire-USNewswire -- Oct. 29/
Copyright©2007 PR Newswire.
All rights reserved